These success, together with a previous report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the strategy of focusing on ACKR3 as a singular method to modulate the opioid program, which could open new therapeutic avenues for opioid-related disorders.A investigation research revealed in Anest